Supporting Innovation and Entrepreneurship for more than 60 years

Welcome to Safeguard Scientifics' Blog, where we share Perspective, Strategy and Insight.

Archive: Array

A Look Ahead

The Role of the Board in the IPO Process

Recently IPO or looking to go public in the next 12-18 months? Then you don’t want to miss the Pre- and Post-IPO Board Forum, hosted by NYSE Governance Services, Corporate Board Member, on Wednesday, December 11, 2013 at the offices of PwC, 3 Embarcadero Center, San Francisco, CA. This Board Forum is targeting newly listed public companies, as well as companies…

Read more

Life Sciences

30 percent of Safeguard’s Partner Companies Ranked on the Deloitte Technology Fast 500

The numbers are in. And we’re excited to announce that six of Safeguard’s partner companies have been named to the Deloitte Technology Fast 500TMList for 2013. Technology Fast 500, conducted by Deloitte LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies—both public and private—in North America. Technology Fast 500 award winners are…

Read more

Corporate

Safeguard Increases Aggregate Partner Company Revenue Guidance for 2013

Safeguard announced that it has increased 2013 aggregate partner company revenue guidance to a range of $285 million to $295 million, up from its initial revenue guidance of $250 million to $270 million. This represents an increase of 44% to 49% as compared to $197.3 million in 2012. Results for Safeguard partner companies are reported on a one-quarter lag basis.…

Read more

Life Sciences

Why VC Interest in Biotechnology Companies Jumped in the Second Quarter of 2013

The second quarter 2013 NVCA numbers came in, and while capital deployments in medical device companies declined 1 percent in both dollars and deals from the first quarter, deployments in biotechnology companies surged 41 percent in dollars and 4 percent in total deals over the same period. Why were venture capitalists more willing to deploy capital in biotech companies than…

Read more

Life Sciences

How the Digital Revolution Will Create Better Health Care

Last night, cardiologist Dr. Eric Topol, chief academic officer of Scripps Health, was a guest on The Colbert Report, where he discussed his new book, “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care.” As part of this 5min segment, Dr. Topol featured Sotera Wireless’ ViSi Mobile device. The Colbert Report Get More: Colbert Report Full…

Read more